Chimerix reported $0 in Debt for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Ardelyx ARDX:US $ 26.14M 6.12M
Chimerix CMRX:US $ 0M 14M
Curis CRIS:US $ 0M 0M
Dynavax Technologies DVAX:US $ 220.76M 0.27M
Emergent Biosolutions EBS:US $ 833.1M 7.9M
Epizyme EPZM:US $ 232.49M 0.38M
Gilead Sciences GILD:US $ 26208M 487M
Glaxosmithkline GSK:US $ 33328M 9155M
Life Technologies LIFE:US $ 0M 0M
Merk MRK:US $ 31794M 1308M
Mirati Therapeutics MRTX:US $ 0M 0M
Novavax NVAX:US $ 440.5M 13.49M
Xoma XOMA:US $ 0 0